- Q4 2023 Sangamo Therapeutics Inc Earnings Call TranscriptMar 13, 2024$0.7851 (-8.83%)Earnings
- Q3 2023 Sangamo Therapeutics Inc Earnings Call TranscriptNov 02, 2023$0.46 (-22.14%)Earnings
- Q2 2023 Sangamo Therapeutics Inc Earnings Call TranscriptAug 08, 2023$1.14 (-2.56%)Earnings
- Sangamo Therapeutics Inc at Barclays Virtual Gene Editing & Therapy Summit TranscriptMay 24, 2023
- Sangamo Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Sangamo Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Sangamo Therapeutics Inc Earnings Call TranscriptApr 27, 2023$1.6 (-0.62%)Earnings
- Sangamo Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 Sangamo Therapeutics Inc Earnings Call TranscriptFeb 22, 2023$2.91 (+2.46%)Earnings
- Sangamo Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Sangamo Therapeutics Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- Q3 2022 Sangamo Therapeutics Inc Earnings Call TranscriptNov 03, 2022$4.15 (-2.58%)Earnings
- Q2 2022 Sangamo Therapeutics Inc Earnings Call TranscriptAug 04, 2022$4.77 (-0.63%)Earnings
- Sangamo Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Sangamo Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptMay 24, 2022
- Sangamo Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Sangamo Therapeutics Inc Earnings Call TranscriptMay 05, 2022$4.3 (-6.11%)Earnings
- Sangamo Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 17, 2022
- Q4 2021 Sangamo Therapeutics Inc Earnings Call TranscriptFeb 24, 2022$5.71 (+6.13%)Earnings
- Sangamo Therapeutics Inc at Barclays Gene Editing & Gene Therapy Summit (Virtual) TranscriptNov 15, 2021
- Q3 2021 Sangamo Therapeutics Inc Earnings Call TranscriptNov 04, 2021$10.89 (+19.15%)Earnings
- Sangamo Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Q2 2021 Sangamo Therapeutics Inc Earnings Call TranscriptAug 05, 2021$9.97 (+5.39%)Earnings
- Sangamo Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2021
- Sangamo Therapeutics Inc Annual Shareholders Meeting TranscriptMay 25, 2021
- Sangamo Therapeutics Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 18, 2021
- Sangamo Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Sangamo Therapeutics Inc Earnings Call TranscriptMay 04, 2021$11.36 (-2.32%)Earnings
- Sangamo Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Sangamo Therapeutics Inc at H C Wainwright Global Life Sciences Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 Sangamo Therapeutics Inc Earnings Call TranscriptFeb 24, 2021$12.52 (+1.54%)Earnings
- Sangamo Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Sangamo Therapeutics Inc at Barclays Virtual Gene Editing & Gene Therapy Summit TranscriptNov 16, 2020
- Sangamo Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 Sangamo Therapeutics Inc Earnings Call TranscriptNov 04, 2020$11.82 (+10.99%)Earnings
- Sangamo Therapeutics Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2020
- Sangamo Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 18, 2020
- Q2 2020 Sangamo Therapeutics Inc Earnings Call TranscriptAug 05, 2020$11.5 (+0.52%)Earnings
- Sangamo Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- Sangamo Therapeutics Inc Annual Shareholders Meeting TranscriptMay 18, 2020
- Sangamo Therapeutics Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 Sangamo Therapeutics Inc Earnings Call TranscriptMay 11, 2020$9.06 (+4.14%)Earnings
- Sangamo Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Q4 2019 Sangamo Therapeutics Inc Earnings and Collaboration Agreement with Biogen Inc Call TranscriptFeb 28, 2020
- Sangamo Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Sangamo Therapeutics Inc R&D Day TranscriptDec 17, 2019
- Q3 2019 Sangamo Therapeutics Inc Earnings Call TranscriptNov 06, 2019$9.46Earnings
- Sangamo Therapeutics Inc at Jefferies Gene Therapy/Editing Summit TranscriptOct 08, 2019
- Sangamo Therapeutics Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Sangamo Therapeutics Inc Earnings Call TranscriptAug 07, 2019$12.17 (+2.79%)Earnings
- Sangamo Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Q1 2019 Sangamo Therapeutics Inc Earnings Call TranscriptMay 08, 2019$11.31 (-0.09%)Earnings
- Sangamo Therapeutics Inc Clinical Development Update Call TranscriptApr 02, 2019
- Sangamo Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2019
- Q4 2018 Sangamo Therapeutics Inc Earnings Call TranscriptFeb 28, 2019$9.01 (-3.33%)Earnings
Sangamo Therapeutics Inc at Barclays Virtual Gene Editing & Therapy Summit Transcript
Good morning, everyone. My name is Gena Wang, and I'm SMID cap biotech analyst at Barclays. Welcome to our 7th Gene Editing & Gene Therapy Summit. I would like to thank all the participants, investors, companies and especially our event team and corporate access team, who made this event possible. And with that, I would like to introduce our next presenter, Mark McClung, Chief Operating Officer from Sangamo. Mark, well, thank you very much for joining us today.
Good morning, Gena. It's a pleasure.
Questions & Answers
Okay. So maybe I will start with your Fabry program, ST-920. So maybe regarding your regulatory path, I know you just received the Fast Track destination, also expect discussion with the FDA to finalize the Phase III trial design in the summer. And so maybe a few questions there. Have
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)